Apelin-13 inhibits apoptosis and excessive autophagy in cerebral ischemia/reperfusion injury

Apelin-13 is a novel endogenous ligand for an angiotensin-like orphan G-protein coupled receptor, and it may be neuroprotective against cerebral ischemia injury. However, the precise mechanisms of the effects of apelin-13 remain to be elucidated. To investigate the effects of apelin-13 on apoptosis...

Full description

Bibliographic Details
Main Authors: Zi-Qi Shao, Shan-Shan Dou, Jun-Ge Zhu, Hui-Qing Wang, Chun-Mei Wang, Bao-Hua Cheng, Bo Bai
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2021-01-01
Series:Neural Regeneration Research
Subjects:
Online Access:http://www.nrronline.org/article.asp?issn=1673-5374;year=2021;volume=16;issue=6;spage=1044;epage=1051;aulast=Shao
_version_ 1818720752165191680
author Zi-Qi Shao
Shan-Shan Dou
Jun-Ge Zhu
Hui-Qing Wang
Chun-Mei Wang
Bao-Hua Cheng
Bo Bai
author_facet Zi-Qi Shao
Shan-Shan Dou
Jun-Ge Zhu
Hui-Qing Wang
Chun-Mei Wang
Bao-Hua Cheng
Bo Bai
author_sort Zi-Qi Shao
collection DOAJ
description Apelin-13 is a novel endogenous ligand for an angiotensin-like orphan G-protein coupled receptor, and it may be neuroprotective against cerebral ischemia injury. However, the precise mechanisms of the effects of apelin-13 remain to be elucidated. To investigate the effects of apelin-13 on apoptosis and autophagy in models of cerebral ischemia/reperfusion injury, a rat model was established by middle cerebral artery occlusion. Apelin-13 (50 μg/kg) was injected into the right ventricle as a treatment. In addition, an SH-SY5Y cell model was established by oxygen-glucose deprivation/reperfusion, with cells first cultured in sugar-free medium with 95% N2 and 5% CO2 for 4 hours and then cultured in a normal environment with sugar-containing medium for 5 hours. This SH-SY5Y cell model was treated with 10–7 M apelin-13 for 5 hours. Results showed that apelin-13 protected against cerebral ischemia/reperfusion injury. Apelin-13 treatment alleviated neuronal apoptosis by increasing the ratio of Bcl-2/Bax and significantly decreasing cleaved caspase-3 expression. In addition, apelin-13 significantly inhibited excessive autophagy by regulating the expression of LC3B, p62, and Beclin1. Furthermore, the expression of Bcl-2 and the phosphatidylinositol-3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) pathway was markedly increased. Both LY294002 (20 μM) and rapamycin (500 nM), which are inhibitors of the PI3K/Akt/mTOR pathway, significantly attenuated the inhibition of autophagy and apoptosis caused by apelin-13. In conclusion, the findings of the present study suggest that Bcl-2 upregulation and mTOR signaling pathway activation lead to the inhibition of apoptosis and excessive autophagy. These effects are involved in apelin-13-induced neuroprotection against cerebral ischemia/reperfusion injury, both in vivo and in vitro. The study was approved by the Animal Ethical and Welfare Committee of Jining Medical University, China (approval No. 2018-JS-001) in February 2018.
first_indexed 2024-12-17T20:27:50Z
format Article
id doaj.art-78979e7c86b64b49bd1a7c10fd717c08
institution Directory Open Access Journal
issn 1673-5374
language English
last_indexed 2024-12-17T20:27:50Z
publishDate 2021-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Neural Regeneration Research
spelling doaj.art-78979e7c86b64b49bd1a7c10fd717c082022-12-21T21:33:42ZengWolters Kluwer Medknow PublicationsNeural Regeneration Research1673-53742021-01-011661044105110.4103/1673-5374.300725Apelin-13 inhibits apoptosis and excessive autophagy in cerebral ischemia/reperfusion injuryZi-Qi ShaoShan-Shan DouJun-Ge ZhuHui-Qing WangChun-Mei WangBao-Hua ChengBo BaiApelin-13 is a novel endogenous ligand for an angiotensin-like orphan G-protein coupled receptor, and it may be neuroprotective against cerebral ischemia injury. However, the precise mechanisms of the effects of apelin-13 remain to be elucidated. To investigate the effects of apelin-13 on apoptosis and autophagy in models of cerebral ischemia/reperfusion injury, a rat model was established by middle cerebral artery occlusion. Apelin-13 (50 μg/kg) was injected into the right ventricle as a treatment. In addition, an SH-SY5Y cell model was established by oxygen-glucose deprivation/reperfusion, with cells first cultured in sugar-free medium with 95% N2 and 5% CO2 for 4 hours and then cultured in a normal environment with sugar-containing medium for 5 hours. This SH-SY5Y cell model was treated with 10–7 M apelin-13 for 5 hours. Results showed that apelin-13 protected against cerebral ischemia/reperfusion injury. Apelin-13 treatment alleviated neuronal apoptosis by increasing the ratio of Bcl-2/Bax and significantly decreasing cleaved caspase-3 expression. In addition, apelin-13 significantly inhibited excessive autophagy by regulating the expression of LC3B, p62, and Beclin1. Furthermore, the expression of Bcl-2 and the phosphatidylinositol-3-kinase (PI3K)/Akt/mammalian target of rapamycin (mTOR) pathway was markedly increased. Both LY294002 (20 μM) and rapamycin (500 nM), which are inhibitors of the PI3K/Akt/mTOR pathway, significantly attenuated the inhibition of autophagy and apoptosis caused by apelin-13. In conclusion, the findings of the present study suggest that Bcl-2 upregulation and mTOR signaling pathway activation lead to the inhibition of apoptosis and excessive autophagy. These effects are involved in apelin-13-induced neuroprotection against cerebral ischemia/reperfusion injury, both in vivo and in vitro. The study was approved by the Animal Ethical and Welfare Committee of Jining Medical University, China (approval No. 2018-JS-001) in February 2018.http://www.nrronline.org/article.asp?issn=1673-5374;year=2021;volume=16;issue=6;spage=1044;epage=1051;aulast=Shaocentral nervous system; brain; brain injury; factor; pathways; apoptosis; autophagy; neuroprotection; regeneration
spellingShingle Zi-Qi Shao
Shan-Shan Dou
Jun-Ge Zhu
Hui-Qing Wang
Chun-Mei Wang
Bao-Hua Cheng
Bo Bai
Apelin-13 inhibits apoptosis and excessive autophagy in cerebral ischemia/reperfusion injury
Neural Regeneration Research
central nervous system; brain; brain injury; factor; pathways; apoptosis; autophagy; neuroprotection; regeneration
title Apelin-13 inhibits apoptosis and excessive autophagy in cerebral ischemia/reperfusion injury
title_full Apelin-13 inhibits apoptosis and excessive autophagy in cerebral ischemia/reperfusion injury
title_fullStr Apelin-13 inhibits apoptosis and excessive autophagy in cerebral ischemia/reperfusion injury
title_full_unstemmed Apelin-13 inhibits apoptosis and excessive autophagy in cerebral ischemia/reperfusion injury
title_short Apelin-13 inhibits apoptosis and excessive autophagy in cerebral ischemia/reperfusion injury
title_sort apelin 13 inhibits apoptosis and excessive autophagy in cerebral ischemia reperfusion injury
topic central nervous system; brain; brain injury; factor; pathways; apoptosis; autophagy; neuroprotection; regeneration
url http://www.nrronline.org/article.asp?issn=1673-5374;year=2021;volume=16;issue=6;spage=1044;epage=1051;aulast=Shao
work_keys_str_mv AT ziqishao apelin13inhibitsapoptosisandexcessiveautophagyincerebralischemiareperfusioninjury
AT shanshandou apelin13inhibitsapoptosisandexcessiveautophagyincerebralischemiareperfusioninjury
AT jungezhu apelin13inhibitsapoptosisandexcessiveautophagyincerebralischemiareperfusioninjury
AT huiqingwang apelin13inhibitsapoptosisandexcessiveautophagyincerebralischemiareperfusioninjury
AT chunmeiwang apelin13inhibitsapoptosisandexcessiveautophagyincerebralischemiareperfusioninjury
AT baohuacheng apelin13inhibitsapoptosisandexcessiveautophagyincerebralischemiareperfusioninjury
AT bobai apelin13inhibitsapoptosisandexcessiveautophagyincerebralischemiareperfusioninjury